The UK NSC recommendation on Hepatitis B screening in pregnancy (currently under review)

 

This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Sep 2017 and is estimated to be completed by Apr 2018.

Recommendation Systematic population screening programme recommended
 
Key downloads
 

Find general information about population health screening.

More about Hepatitis B

Hepatitis B and C are serious viral diseases which affect the liver and are blood borne. Both viruses may cause acute illness. However, in the majority of children these viruses become chronic with liver damage only becoming apparent in adulthood. The common way of spreading or acquiring the infection are babies born to hepatitis B or C positive mothers, sharing of toothbrushes or razors amongst family members, or intravenous drug abuse. 

Mothers can pass on their infection to their baby. An infected baby may develop liver problems later in life. This can be prevented by immunisation of the newborn baby. 

» Read more about Hepatitis B on NHS Choices

» Read more about screening for Hepatitis B

Stakeholders

British Society for Immunology
Faculty of Public Health
Hepatitis B Foundation UK
Hepatitis B Positive Trust
Institute of Child Health
Royal College of General Practitioners
Royal College of Midwives
Royal College of Obstetricians and Gynaecologists
Royal College of Paediatrics and Child Health
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

More options

Go to top